{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:53:56Z","timestamp":1764510836583,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Mycobacterium ulcerans<\/jats:italic> causes Buruli Ulcer, a neglected infectious skin disease that typically progresses from an early non-ulcerative lesion to an ulcer with undermined edges. If not promptly treated, these lesions can lead to severe disfigurement and disability. The standard antibiotic regimen for Buruli Ulcer treatment has been oral rifampicin combined with intramuscular streptomycin administered daily for 8\u2009weeks. However, there has been a recent shift toward replacing streptomycin with oral clarithromycin. Despite the advantages of this antibiotic regimen, it is limited by low compliance, associated side effects, and refractory efficacy for severe ulcerative lesions. Therefore, new drug candidates with a safer pharmacological spectrum and easier mode of administration are needed. Statins are lipid-lowering drugs broadly used for dyslipidemia treatment but have also been reported to have several pleiotropic effects, including antimicrobial activity against fungi, parasites, and bacteria. In the present study, we tested the susceptibility of <jats:italic>M. ulcerans<\/jats:italic> to several statins, namely atorvastatin, simvastatin, lovastatin and fluvastatin. Using broth microdilution assays and cultures of <jats:italic>M. ulcerans<\/jats:italic>-infected macrophages, we found that atorvastatin, simvastatin and fluvastatin had antimicrobial activity against <jats:italic>M. ulcerans<\/jats:italic>. Furthermore, when using the <jats:italic>in vitro<\/jats:italic> checkerboard assay, the combinatory additive effect of atorvastatin and fluvastatin with the standard antibiotics used for Buruli Ulcer treatment highlighted the potential of statins as adjuvant drugs. In conclusion, statins hold promise as potential treatment options for Buruli Ulcer. Further studies are necessary to validate their effectiveness and understand the mechanism of action of statins against <jats:italic>M. ulcerans<\/jats:italic>.<\/jats:p>","DOI":"10.3389\/fmicb.2023.1266261","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T21:41:48Z","timestamp":1696110108000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Repurposing of statins for Buruli Ulcer treatment: antimicrobial activity against Mycobacterium ulcerans"],"prefix":"10.3389","volume":"14","author":[{"given":"Juan","family":"Dominguez","sequence":"first","affiliation":[]},{"given":"Ana I.","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Ana R.","family":"Pacheco","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pedrosa","sequence":"additional","affiliation":[]},{"given":"Alexandra G.","family":"Fraga","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,9,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.33321\/cdi.2020.44.93","article-title":"Buruli ulcer: a new case definition for Victoria","volume":"44","author":"Betts","year":"2020","journal-title":"Commun. Dis. Intell."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1128\/jb.178.1.19-23.1996","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase from Haloferax volcanii: purification, characterization, and expression in Escherichia coli","volume":"178","author":"Bischoff","year":"1996","journal-title":"J. Bacteriol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2125.2011.03907.x","article-title":"What is a relevant statin concentration in cell experiments claiming pleiotropic effects?","volume":"72","author":"Bjorkhem-Bergman","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/mgme.1998.2786","article-title":"Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme a reductase","volume":"66","author":"Bochar","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1128\/JB.00488-09","article-title":"Mycobacterium tuberculosis is able to accumulate and utilize cholesterol","volume":"191","author":"Brzostek","year":"2009","journal-title":"J. Bacteriol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.tube.2008.11.001","article-title":"Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models","volume":"89","author":"Caceres","year":"2009","journal-title":"Tuberculosis (Edinb.)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1128\/AAC.00175-07","article-title":"Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease)","volume":"51","author":"Chauty","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"687585","DOI":"10.3389\/fcvm.2021.687585","article-title":"Hydrophilic or lipophilic statins?","volume":"8","author":"Climent","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/s0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins","volume":"84","author":"Corsini","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/Jcm.01121-14","article-title":"When does 2 plus 2 equal 5? A review of antimicrobial synergy testing","volume":"52","author":"Doern","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/infdis\/jiz517","article-title":"Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice","volume":"221","author":"Dutta","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/82_2012_299","article-title":"Mycobacterium tuberculosis metabolism and host interaction: mysteries and paradoxes","volume":"374","author":"Ehrt","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2183\/pjab.86.484","article-title":"A historical perspective on the discovery of statins","volume":"86","author":"Endo","year":"2010","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/AAC.49.8.3182-3186.2005","article-title":"Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans","volume":"49","author":"Etuaful","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0007113","DOI":"10.1371\/journal.pntd.0007113","article-title":"Antimicrobial activity of mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection","volume":"13","author":"Fraga","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e0007689","DOI":"10.1371\/journal.pntd.0007689","article-title":"Paradoxical reactions in Buruli ulcer after initiation of antibiotic therapy: relationship to bacterial load","volume":"13","author":"Frimpong","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1126\/science.288.5471.1647","article-title":"Essential role for cholesterol in entry of mycobacteria into macrophages","volume":"288","author":"Gatfield","year":"2000","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-11114-4_7","article-title":"Mycolactone: More than just a Cytotoxin","volume-title":"Buruli ulcer:","author":"Guenin-Mace","year":"2019"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/2211352516666180629124433","article-title":"Comparison of minimum inhibitory concentration (MIC) value of statin drugs: a systematic review","volume":"17","author":"Gupta","year":"2019","journal-title":"Anti-Infect. Agents."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/jac\/11.5.427","article-title":"The fractional inhibitory concentration (FIC) index as a measure of synergy","volume":"11","author":"Hall","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1128\/AAC.00192-16","article-title":"Is there potential for repurposing statins as novel antimicrobials?","volume":"60","author":"Hennessy","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2958.2009.06957.x","article-title":"3-Ketosteroid 9alpha-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis","volume":"75","author":"Hu","year":"2010","journal-title":"Mol. Microbiol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(20)30478-5","article-title":"Buruli ulcer: cured by 8 weeks of oral antibiotics?","volume":"395","author":"Johnson","year":"2020","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1110\/ps.9.6.1226","article-title":"Dual coenzyme specificity of Archaeoglobus fulgidus HMG-CoA reductase","volume":"9","author":"Kim","year":"2000","journal-title":"Protein Sci."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1128\/AAC.03763-14","article-title":"Compliance with antimicrobial therapy for Buruli ulcer","volume":"58","author":"Klis","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fphar.2017.00597","article-title":"Population-based case-control study assessing the association between statins use and pulmonary tuberculosis in Taiwan","volume":"8","author":"Liao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1128\/AAC.01826-13","article-title":"Statins increase rifampin mycobactericidal effect","volume":"58","author":"Lobato","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1161\/01.ATV.0000143858.15909.29","article-title":"Statin inhibition of fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol","volume":"24","author":"Loike","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mib.2015.10.002","article-title":"Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection","volume":"29","author":"Lovewell","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1128\/IAI.00037-08","article-title":"Hypercholesterolemia impairs immunity to tuberculosis","volume":"76","author":"Martens","year":"2008","journal-title":"Infect. Immun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0006-2952(95)02230-9","article-title":"A checkerboard method to evaluate interactions between drugs","volume":"51","author":"Martinez-Irujo","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.53854\/liim-3002-4","article-title":"Further insights into to the role of statins against active tuberculosis: systematic review and meta-analysis","volume":"30","author":"Meregildo-Rodriguez","year":"2022","journal-title":"Infez. Med."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/s0021-9150(00)00417-2","article-title":"Hydroxymethylglutaryl-coenzyme a reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells","volume":"153","author":"Montero","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1128\/IAI.00893-09","article-title":"A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol","volume":"78","author":"Nesbitt","year":"2010","journal-title":"Infect. Immun."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"17693","DOI":"10.1038\/srep17693","article-title":"Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease","volume":"5","author":"Niang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e1006814","DOI":"10.1371\/journal.ppat.1006814","article-title":"The potent effect of mycolactone on lipid membranes","volume":"14","author":"Nitenberg","year":"2018","journal-title":"PLoS Pathog."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5694\/mja13.11331","article-title":"Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update","volume":"200","author":"O'Brien","year":"2014","journal-title":"Med. J. Aust."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"8304524","DOI":"10.1155\/2016\/8304524","article-title":"Susceptibility profiles of Mycobacterium ulcerans isolates to streptomycin and rifampicin in two districts of the eastern region of Ghana","volume":"2016","author":"Owusu","year":"2016","journal-title":"Int. J. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/jit550","article-title":"Statin therapy reduces the Mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation","volume":"209","author":"Parihar","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0140-6736(20)30047-7","article-title":"Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial","volume":"395","author":"Phillips","year":"2020","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/cid\/ciu584","article-title":"Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection","volume":"59","author":"Pommelet","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1871526518666180806123230","article-title":"Repurposing of existing statin drugs for treatment of microbial infections: how much promising?","volume":"19","author":"Rana","year":"2019","journal-title":"Infect. Disord. Drug Targets"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1080\/21505594.2021.1929749","article-title":"Transcriptional adaptation of Mycobacterium ulcerans in an original mouse model: new insights into the regulation of mycolactone","volume":"12","author":"Robbe-Saule","year":"2021","journal-title":"Virulence"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"86a","DOI":"10.1016\/j.bpj.2012.11.515","article-title":"Statins Alter lipid bilayer properties","volume":"104","author":"Sanford","year":"2013","journal-title":"Biophys. J."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/jac\/dku166","article-title":"Simvastatin increases the in vivo activity of the first-line tuberculosis regimen","volume":"69","author":"Skerry","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3945\/jn.115.228049","article-title":"Dietary cholesterol increases the risk whereas PUFAs reduce the risk of active tuberculosis in Singapore Chinese","volume":"146","author":"Soh","year":"2016","journal-title":"J. Nutr."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1101\/gr.5942807","article-title":"Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer","volume":"17","author":"Stinear","year":"2007","journal-title":"Genome Res."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/1346-8138.12851","article-title":"Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan","volume":"42","author":"Sugawara","year":"2015","journal-title":"J. Dermatol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e1004679","DOI":"10.1371\/journal.ppat.1004679","article-title":"Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment","volume":"11","author":"VanderVen","year":"2015","journal-title":"PLoS Pathog."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1128\/JB.182.18.5147-5152.2000","article-title":"Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme a reductase of Staphylococcus aureus","volume":"182","author":"Wilding","year":"2000","journal-title":"J. Bacteriol."},{"year":"2004","key":"ref55"},{"year":"2012","key":"ref56"},{"volume-title":"Buruli ulcer (","year":"2023","key":"ref57"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e1000344","DOI":"10.1371\/journal.ppat.1000344","article-title":"Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis","volume":"5","author":"Yam","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1021\/bi9005418","article-title":"Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis","volume":"48","author":"Yang","year":"2009","journal-title":"Biochemistry"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1266261\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T21:41:51Z","timestamp":1696110111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1266261\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,29]]},"references-count":59,"alternative-id":["10.3389\/fmicb.2023.1266261"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1266261","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2023,9,29]]},"article-number":"1266261"}}